journal article·2022-04

A Transformable Amphiphilic and Block Polymer−Dendron Conjugate for Enhanced Tumor Penetration and Retention with Cellular Homeostasis Perturbation via Membrane Flow

Lei Gu, Zhenyu Duan, Xiaoting Chen, Xiaoling Li, Qiang Luo, Apanpreet Bhamra, Dayi Pan, Hongyan Zhu, Xiaohe Tian, Rongjun Chen, Zhongwei Gu, Hu Zhang, Zhiyong Qian, Qiyong Gong, Kui Luo

Advanced Materials· Volume 34· Issue 16
Publisher page

Abstract

Abstract Efficient penetration and retention of therapeutic agents in tumor tissues can be realized through rational design of drug delivery systems. Herein, a polymer−dendron conjugate, POEGMA‐b‐p(GFLG‐Dendron‐Ppa) (GFLG‐DP), is presented, which allows a cathepsin‐B‐triggered stealthy‐to‐sticky structural transformation. The compositions and ratios are optimized through dissipative particle dynamics simulations. GFLG‐DP displays tumor‐specific transformation and the consequently released dendron‐Ppa is found to effectively accumulate on the tumor cell membrane. The interaction between the dendron‐Ppa and the tumor cell membrane results in intracellular and intercellular transport via membrane flow, thus achieving efficient deep penetration and prolonged retention of therapeutic agents in the solid tumor tissues. Meanwhile, the interaction of dendron‐Ppa with the endoplasmic reticulum disrupts cell homeostasis, making tumor cells more vulnerable and susceptible to photodynamic therapy. This platform represents a versatile approach to augmenting the tumor therapeutic efficacy of a nanomedicine via manipulation of its interactions with tumor membrane systems.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Huaxi MR Research Center (HMRRC) Animal Experimental Center Department of Radiology National Clinical Research Center for Geriatrics Frontiers Science Center for Disease‐Related Molecular Network State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu 610041 China

Department of Chemical Engineering Imperial College London South Kensington Campus London SW7 2AZ UK

Functional and Molecular Imaging Key Laboratory of Sichuan Province and Research Unit of Psychoradiology Chinese Academy of Medical Sciences Chengdu 610041 China

Amgen Bioprocessing Centre Keck Graduate Institute Claremont CA 91711 USA

Funding

National Natural Science Foundation of China · West China Hospital, Sichuan University · China Postdoctoral Science Foundation

References (56)

Show source-provided references
1. 10.1038/s41565-019-0567-y10.1038/s41565-019-0567-y ↗
2. 10.1002/advs.20170051310.1002/advs.201700513 ↗
3. 10.1038/s41551-021-00701-410.1038/s41551-021-00701-4 ↗
4. 10.1038/s41467-021-22594-210.1038/s41467-021-22594-2 ↗
5. 10.1093/nsr/nwx06210.1093/nsr/nwx062 ↗
6. 10.1039/D0CS00011F10.1039/D0CS00011F ↗
7. 10.1002/marc.20210026210.1002/marc.202100262 ↗
8. Gerweck L. E. · Cancer Res. · 1996 · 56 · 1194
9. 10.1038/s41565-019-0485-z10.1038/s41565-019-0485-z ↗
10. 10.1016/j.addr.2020.07.02110.1016/j.addr.2020.07.021 ↗
11. 10.1038/ncomms1499810.1038/ncomms14998 ↗
12. 10.1002/adma.20180579810.1002/adma.201805798 ↗
13. 10.1002/jcb.2072010.1002/jcb.20720 ↗
14. 10.1593/neo.1394610.1593/neo.13946 ↗
15. 10.1016/j.celrep.2017.11.02610.1016/j.celrep.2017.11.026 ↗
16. 10.1002/adma.20210459410.1002/adma.202104594 ↗
17. 10.1002/advs.20190324310.1002/advs.201903243 ↗
18. 10.1002/adfm.20211040810.1002/adfm.202110408 ↗
19. 10.1002/marc.20210011110.1002/marc.202100111 ↗
20. 10.1002/adma.20180497110.1002/adma.201804971 ↗
21. 10.1038/s41467-019-12848-510.1038/s41467-019-12848-5 ↗
22. 10.1002/advs.20210274110.1002/advs.202102741 ↗
23. 10.1002/adfm.20200376410.1002/adfm.202003764 ↗
24. 10.1002/adma.20190158610.1002/adma.201901586 ↗
25. 10.1002/adma.20190749010.1002/adma.201907490 ↗
26. 10.1016/j.apsb.2021.05.00310.1016/j.apsb.2021.05.003 ↗
27. 10.1042/bj217002710.1042/bj2170027 ↗
28. 10.1038/nrm275510.1038/nrm2755 ↗
29. 10.1186/s12915-017-0432-010.1186/s12915-017-0432-0 ↗
30. 10.1038/s41551-016-000210.1038/s41551-016-0002 ↗
31. 10.1002/adhm.20180117710.1002/adhm.201801177 ↗
32. 10.1021/mp400703d10.1021/mp400703d ↗
33. 10.1038/s41565-020-00782-310.1038/s41565-020-00782-3 ↗
34. 10.1038/nrd103310.1038/nrd1033 ↗
35. 10.1016/j.addr.2020.10.00110.1016/j.addr.2020.10.001 ↗
36. 10.1002/adma.20200001310.1002/adma.202000013 ↗
37. 10.1016/j.apsb.2019.08.01110.1016/j.apsb.2019.08.011 ↗
38. 10.1021/acsnano.0c0219710.1021/acsnano.0c02197 ↗
39. 10.1016/j.addr.2019.11.00510.1016/j.addr.2019.11.005 ↗
40. 10.1002/marc.20210011110.1002/marc.202100111 ↗
41. 10.1021/jacs.8b0501410.1021/jacs.8b05014 ↗
42. 10.1016/j.biomaterials.2018.10.00510.1016/j.biomaterials.2018.10.005 ↗
43. 10.1002/anie.20201639910.1002/anie.202016399 ↗
44. 10.1023/A:102300771775710.1023/A:1023007717757 ↗
45. 10.1038/nrc402710.1038/nrc4027 ↗
46. 10.1242/jcs.110.2.10510.1242/jcs.110.2.105 ↗
47. 10.1038/icb.2011.2010.1038/icb.2011.20 ↗
48. 10.1038/ncomms1514410.1038/ncomms15144 ↗
49. 10.1073/pnas.091060310610.1073/pnas.0910603106 ↗
50. 10.1126/science.117462110.1126/science.1174621 ↗
51. 10.1038/nature1347410.1038/nature13474 ↗
52. 10.1038/nature0796210.1038/nature07962 ↗
53. 10.1016/j.bbamcr.2013.06.02810.1016/j.bbamcr.2013.06.028 ↗
54. 10.1016/j.nantod.2021.10135510.1016/j.nantod.2021.101355 ↗
55. 10.1089/ars.2007.9.4910.1089/ars.2007.9.49 ↗
56. 10.1038/onc.2008.30110.1038/onc.2008.301 ↗